Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/23/2025

Eosinophilic Esophagitis Treatment Guidelines

First-Line Therapy

  • The American Gastroenterological Association recommends proton pump inhibitor therapy (e.g., omeprazole 20 mg twice daily) for 8-12 weeks as first-line treatment for eosinophilic esophagitis, due to its safety profile and effectiveness 1, 2, 3
  • Histological response should be assessed while on treatment, as symptoms may not correlate with histological activity, with a recommendation level supported by moderate-quality evidence 4

Second-Line Therapy

  • Topical steroids are highly effective for inducing both histological and clinical remission in patients who fail proton pump inhibitor therapy, with high-quality evidence and a strong recommendation level 1, 2

Treatment of Fibrostenotic Disease

  • Endoscopic dilatation is effective and safe for improving symptoms in patients with strictures, and a combined approach of dilatation with topical steroids yields better clinical outcomes 1, 5

Dietary Management

  • Elimination diets are effective in achieving clinico-histological remission, with the six food elimination diet having higher histological remission rates than two or four food elimination diets, but with lower compliance 4, 6, 7

Maintenance Therapy

  • For patients who achieve histological response, maintenance treatment with proton pump inhibitors or topical steroids is recommended, as relapse rates are high after withdrawal, with a strong recommendation level supported by moderate-quality evidence 2, 5

Important Clinical Considerations

  • The recommended dose for eosinophilic esophagitis is omeprazole 20 mg twice daily, with treatment continuing for at least 8-12 weeks before assessing histological response, and repeat endoscopy with biopsy necessary to assess treatment response while on therapy 1, 2, 3, 4

REFERENCES